Cargando…

Targeting HSF1 for cancer treatment: mechanisms and inhibitor development

Heat Shock Factor 1 (HSF1) is a master regulator of heat shock responsive signaling. In addition to playing critical roles in cellular heat shock response, emerging evidence suggests that HSF1 also regulates a non-heat shock responsive transcriptional network to handle metabolic, chemical, and genet...

Descripción completa

Detalles Bibliográficos
Autores principales: Chin, Yeh, Gumilar, Khanisyah E, Li, Xing-Guo, Tjokroprawiro, Brahmana A., Lu, Chien-Hsing, Lu, Jianrong, Zhou, Ming, Sobol, Robert W., Tan, Ming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10157728/
https://www.ncbi.nlm.nih.gov/pubmed/37153737
http://dx.doi.org/10.7150/thno.82431
_version_ 1785036816921919488
author Chin, Yeh
Gumilar, Khanisyah E
Li, Xing-Guo
Tjokroprawiro, Brahmana A.
Lu, Chien-Hsing
Lu, Jianrong
Zhou, Ming
Sobol, Robert W.
Tan, Ming
author_facet Chin, Yeh
Gumilar, Khanisyah E
Li, Xing-Guo
Tjokroprawiro, Brahmana A.
Lu, Chien-Hsing
Lu, Jianrong
Zhou, Ming
Sobol, Robert W.
Tan, Ming
author_sort Chin, Yeh
collection PubMed
description Heat Shock Factor 1 (HSF1) is a master regulator of heat shock responsive signaling. In addition to playing critical roles in cellular heat shock response, emerging evidence suggests that HSF1 also regulates a non-heat shock responsive transcriptional network to handle metabolic, chemical, and genetic stress. The function of HSF1 in cellular transformation and cancer development has been extensively studied in recent years. Due to important roles for HSF1 for coping with various stressful cellular states, research on HSF1 has been very active. New functions and molecular mechanisms underlying these functions have been continuously discovered, providing new targets for novel cancer treatment strategies. In this article, we review the essential roles and mechanisms of HSF1 action in cancer cells, focusing more on recently discovered functions and their underlying mechanisms to reflect the new advances in cancer biology. In addition, we emphasize new advances with regard to HSF1 inhibitors for cancer drug development.
format Online
Article
Text
id pubmed-10157728
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Ivyspring International Publisher
record_format MEDLINE/PubMed
spelling pubmed-101577282023-05-05 Targeting HSF1 for cancer treatment: mechanisms and inhibitor development Chin, Yeh Gumilar, Khanisyah E Li, Xing-Guo Tjokroprawiro, Brahmana A. Lu, Chien-Hsing Lu, Jianrong Zhou, Ming Sobol, Robert W. Tan, Ming Theranostics Review Heat Shock Factor 1 (HSF1) is a master regulator of heat shock responsive signaling. In addition to playing critical roles in cellular heat shock response, emerging evidence suggests that HSF1 also regulates a non-heat shock responsive transcriptional network to handle metabolic, chemical, and genetic stress. The function of HSF1 in cellular transformation and cancer development has been extensively studied in recent years. Due to important roles for HSF1 for coping with various stressful cellular states, research on HSF1 has been very active. New functions and molecular mechanisms underlying these functions have been continuously discovered, providing new targets for novel cancer treatment strategies. In this article, we review the essential roles and mechanisms of HSF1 action in cancer cells, focusing more on recently discovered functions and their underlying mechanisms to reflect the new advances in cancer biology. In addition, we emphasize new advances with regard to HSF1 inhibitors for cancer drug development. Ivyspring International Publisher 2023-04-17 /pmc/articles/PMC10157728/ /pubmed/37153737 http://dx.doi.org/10.7150/thno.82431 Text en © The author(s) https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.
spellingShingle Review
Chin, Yeh
Gumilar, Khanisyah E
Li, Xing-Guo
Tjokroprawiro, Brahmana A.
Lu, Chien-Hsing
Lu, Jianrong
Zhou, Ming
Sobol, Robert W.
Tan, Ming
Targeting HSF1 for cancer treatment: mechanisms and inhibitor development
title Targeting HSF1 for cancer treatment: mechanisms and inhibitor development
title_full Targeting HSF1 for cancer treatment: mechanisms and inhibitor development
title_fullStr Targeting HSF1 for cancer treatment: mechanisms and inhibitor development
title_full_unstemmed Targeting HSF1 for cancer treatment: mechanisms and inhibitor development
title_short Targeting HSF1 for cancer treatment: mechanisms and inhibitor development
title_sort targeting hsf1 for cancer treatment: mechanisms and inhibitor development
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10157728/
https://www.ncbi.nlm.nih.gov/pubmed/37153737
http://dx.doi.org/10.7150/thno.82431
work_keys_str_mv AT chinyeh targetinghsf1forcancertreatmentmechanismsandinhibitordevelopment
AT gumilarkhanisyahe targetinghsf1forcancertreatmentmechanismsandinhibitordevelopment
AT lixingguo targetinghsf1forcancertreatmentmechanismsandinhibitordevelopment
AT tjokroprawirobrahmanaa targetinghsf1forcancertreatmentmechanismsandinhibitordevelopment
AT luchienhsing targetinghsf1forcancertreatmentmechanismsandinhibitordevelopment
AT lujianrong targetinghsf1forcancertreatmentmechanismsandinhibitordevelopment
AT zhouming targetinghsf1forcancertreatmentmechanismsandinhibitordevelopment
AT sobolrobertw targetinghsf1forcancertreatmentmechanismsandinhibitordevelopment
AT tanming targetinghsf1forcancertreatmentmechanismsandinhibitordevelopment